Archive for the ‘Uncategorized’ Category

The meaning of colour – so what for Pharma?

Thursday, January 19th, 2012

PANTONE® has recently announced PANTONE® 17-1463 Tangerine Tango, a dramatic reddish orange, as 2012’s colour of the year.

According to Leatrice Eiseman, executive director of the Pantone Colour Institute®, “Tangerine Tango combines the vivaciousness and adrenaline rush of red with the friendliness and warmth of yellow, to form a high-visibility, magnetic hue that emanates heat and energy”.

What does Tangerine Tango mean to you? A single colour has the ability to evoke all of the senses, creating a wealth of thoughts, feelings and visions in the mind of the viewer in seconds. Colour is therefore the mainstay of design across a range of industries, the pharmaceutical industry included.

Communication and marketing within the pharmaceutical industry is more important today than it has ever been and colour is an essential component of brand development and campaign identity.  Think pink and breast cancer immediately springs to mind; think blue think Viagra, and so on…  consider whether tranquil blue or fiery red represent a good night’s sleep and the answer is immediately obvious.

Consequently, pharmaceutical companies are continuing to invest in ever more daring design options to support and enhance their brands.  So, with over 13,500 PANTONE® colours to choose from, which will be critical to the pharmaceutical industry’s next blockbuster brand?  Tangerine Tango perhaps?

Source: www.Pantone.com

Creative engagement for healthy apps?

Wednesday, December 14th, 2011

Did you know that Apple’s App Store currently offers 9,000 mobile health apps (including nearly 1,500 cardio fitness apps, over 1,300 diet apps, over 1,000 stress and relaxation apps, and over 650 women’s health apps) and by mid 2012, this number is expected to reach 13,000*.  Impressive? The sheer quantity available is irrelevant unless there is a demand for such apps. According to Juniper Research, mobile healthcare applications for tablets and smartphones are set to reach 44 million downloads by next year, growing to 142 million downloads by 2016. But how many of these apps actually get used?

Research has found that about 20 per cent of users return to an app after the first day they downloaded it but that the average app has a less than five per cent chance of being used for more than 30 days. Furthermore, around 20 per cent of the free apps available in the Android Market have not even clocked 100 downloads.

This is why creativity and engagement is key. Identifying a niche that will entertain, educate or ease the life of the consumer is vital to its success. But in this increasingly crowded marketplace, both creativity and engagement are crucial to differentiate and activate demand but it can come in different forms – from a quirky idea to impressive use of technology.

Take for example, the augmented reality (AR) app called Lungs designed to show smokers the damage caused by cigarettes. Users can control settings to reflect their own experience based on factors such as their age and how many cigarettes they smoke each day; these all impact on both the visual representation and ‘time taken for lungs to recover’ statistic.

Or how about the BeerGut Fitness app, the calorie check book that will assist you in avoiding the dreaded beer gut telling you whether you’ve earned a drink or need to exercise?

With NHS waiting lists growing daily and falling disposable income making private healthcare more unaffordable, combined with an increasingly informed patient base, the market is ripe for the countless new apps and devices actively targeting consumers keen on preventing, examining, improving and managing their health. So the question remains, is this a route more healthcare companies should be focusing in on in 2012?
In a world where audiences are publicly disclosing increasing amounts of personal information about their lives on Facebook, Twitter and other social networks, health apps are becoming more relevant and increasingly invaluable to companies wishing to have a social media presence. However, it is clear that without a healthy dose of engaging creativity many of these apps are destined to fall by the wayside.

* (Source: MobiHealthNews, September 2011).

Why we must listen to the internet

Thursday, June 24th, 2010

A recent PriceWaterhouseCoopers survey of 3,500 consumers in seven countries found that more people use the internet (48 per cent) than arrange a visit to their doctor (43 per cent) to find information to inform decisions about their healthcare. As such, social media sites like www.patientslikeme.com which enables people to share information with each other about various health topics are gaining in popularity.

(more…)

Could ‘bigger picture’ evidence increase pharma drug sales?

Thursday, May 27th, 2010

Earlier this week Reuters profiled a study by almost 150 researchers, who spent two years promoting efficacy and cost-effectiveness data for a blood pressure drug. This was not a pharma funded exercise for a new blockbuster therapy, but part of a study to highlight that sometimes older, cheaper drugs are more effective than newer medications. This turns the traditional model of medical education on its head, and has left many scratching theirs about what this could mean for pharma. Is this the start of something significant?

(more…)

Continuing medical education: GSK policy change

Thursday, September 24th, 2009

This week GSK announced an overhaul to its medical education programme: GSK CME will now be led by programs run by national professional medical associations or teaching hospitals, instead of commercial med-ed and communication companies. While other companies have adopted similar policies ahead of GSK, this latest move still poses some interesting questions for the reputation of medical education overall.

(more…)